Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
Background: Negative symptoms and diminished cognitive ability are also considered as core features of schizophrenia. There are many studies in which negative symptoms and cognitive impairments are individually treated with atypical antipsychotic in comparison with either a placebo or a typical anti...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
| Series: | Industrial Psychiatry Journal |
| Subjects: | |
| Online Access: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2014;volume=23;issue=1;spage=27;epage=35;aulast=Kumar |